New transplant method tested for tough blood cancers
NCT ID NCT02623439
Summary
This study tested a modified bone marrow transplant procedure for adults with serious blood cancers like leukemia and lymphoma. It aimed to see if using a partially mismatched donor (like a family member) followed by a specific drug (cyclophosphamide) could control the cancer and be safe. The main goal was to measure how many patients were still alive 180 days after the transplant.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMATOLOGIC MALIGNANCIES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
UCSD Medical Center
La Jolla, California, 92093, United States
Conditions
Explore the condition pages connected to this study.